Halobetasol propionate foam approved for treatment of plaque psoriasis in teensSeptember 22nd 2021
The US Food and Drug Administration has approved halobetasol propionate foam, 0.05%, a potent topical corticosteroid, for the treatment of plaque psoriasis in adolescent patients.
Addressing sunscreen controversiesMay 13th 2021
Sunscreen is a necessary preventive tool. However, there are concerns about UV agent absorption, environmental impact, and possible correlations with frontal fibrosing alopecia (FFA). Here is a look at whether those worries are justified by research.
What you need to know about atopic dermatitisApril 12th 2021
Atopic dermatitis is a chronic, inflammatory skin condition that affects 15% to 20% of children and 1% to 3% of adults in the United States. The prevalence of atopic dermatitis, which is also known as eczema, is increasing in developing and industrialized countries.
Disseminated erythema migrans as a result of Lyme diseaseMarch 5th 2021
A 17-year-old male patient presents with multiple lesions developed on his trunk, face, and extremities that had previously been solitary, red expanding lesion on his right arm at the site of a tick bite that occurred during a hike.
Recurrence of infantile hemangioma? Consider a second round of propranololFebruary 1st 2021
Using oral propranolol to treat infantile hemangioma is a normal clinical course. When faced with a recurrence of the hemangioma, is a second course of propranolol warranted?